Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | XP | ROL |
|---|---|---|
| Price | $28.15 | $29.69 |
| Change today | ▲ 30.93% | ▼ 1.56% |
| Market cap | $14.28B | $14.29B |
| Return, 3 months | +76.3% | -31.6% |
| Return, year to date | +74.2% | -50.0% |
| Return, 1 year | +68.2% | -48.3% |
| P/E (TTM) | 13.9 | 27.0 |
| P/B | 2.9 | 10.0 |
| P/E percentile vs own 5y | – | 0th |
| Dividend yield | 1.39% | 2.40% |
| Revenue growth (YoY, latest qtr) | – | +7.9% |
| Net profit growth (YoY) | – | +1.7% |
| Gross margin | – | 52.4% |
| Operating margin | – | 18.7% |
| Net margin | – | 13.6% |
| Return on equity | – | 37.0% |
| Analyst target vs. price | – | +40.9% |
| Analyst buy share | – | 38% |
| RSI (14) | 88 | 25 |
| 30-day volatility | 84.2% | 29.3% |
| Max drawdown, 1 year | -34.1% | -54.2% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
